Dexcom scores pediatric expansion for OTC Stelo glucose monitor

The U.S. Food and Drug Administration (FDA) on Friday cleared Dexcom Inc.‘s DXCM Stelo Glucose Biosensor System for ...
CNET

The FDA Just Cleared the First OTC Continuous Glucose Monitor for Children

Stelo can now be marketed for children 2 years of age and older who do not use insulin.
TechCrunch

Oura valued at $5B following deal with medical device firm Dexcom

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom. The investment marks Oura’s Series D funding round and brings the company’s ...
Healio

FDA clears OTC CGM for children aged 2 years and older who do not use insulin

The FDA has announced additional marketing clearance for the Dexcom Stelo Glucose Biosensor System for children aged 2 years ...
CNET

Oura Rings Will Soon Work With Dexcom to Connect the Dots Between Activity, Food and Blood Sugar

Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the companies' products to work together, with the goal being to help users see how nutrition and ...
Nasdaq

DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal

DexCom DXCM recently announced that it has received FDA clearance for its CGM-integrated basal insulin dosing optimizer, Dexcom Smart Basal, for use by adults with Type 2 diabetes on glargine U-100 ...
Business Wire

Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose ...
MobiHealthNews

Dexcom files for patent for smartphone-connected continuous glucose monitoring

San Diego-based Dexcom, a maker of continuous glucose monitors, has filed for a patent for a system that would integrate a smartphone with a Dexcom device, detailing some of the features such a device ...
Reuters

Smart ring maker Ōura valued at over $5 bln after Dexcom funding

Nov 19 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab said on Tuesday it will invest $75 million in Ōura's latest funding round, valuing the smart ring maker at over $5 billion. Ōura, ...
The Motley Fool

If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today

DexCom develops and markets continuous glucose monitoring (CGM) systems, a type of device that continuously tracks blood sugar levels. The technology isn't exactly new anymore, and it has enjoyed ...
Newsweek

‘It’s Life-Threatening’—Dexcom G7 Users Say Glucose Monitor Is Failing Them

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. People with Type 1 diabetes are estimated to make up to 180 more ...
Zacks Investment Research on MSN

Here's why you should retain DexCom stock in your portfolio

DexCom, Inc. DXCM is well-positioned for growth in the coming quarters, supported by the significant potential of the ...